CLARINEX Tablets, Oral Solution, or RediTabs Tablets may be taken without regard
to meals. Place CLARINEX (desloratadine) RediTabs Tablets on the tongue and
allow to disintegrate before swallowing. Tablet disintegration occurs rapidly.
Administer with or without water. Take tablet immediately after opening the
The age-appropriate dose of CLARINEX Oral Solution should be administered with a
commercially available measuring dropper or syringe that is calibrated to
deliver 2 mL and 2.5 mL (one-half teaspoon).
Adults and adolescents 12 years of age and over:
The recommended dose of CLARINEX Tablets or CLARINEX RediTabs Tablets is one
5-mg tablet once daily. The recommended dose of CLARINEX Oral Solution is 2
teaspoonfuls (5 mg in 10 mL) once daily.
Children 6 to 11 years of age:
The recommended dose of CLARINEX Oral Solution is 1 teaspoonful (2.5 mg in 5 mL)
once daily. The recommended dose of CLARINEX RediTabs Tablets is one 2.5-mg
tablet once daily.
Children 12 months to 5 years of age:
The recommended dose of CLARINEX Oral Solution is one-half teaspoonful (1.25 mg
in 2.5 mL) once daily.
Children 6 to 11 months of age:
The recommended dose of CLARINEX Oral Solution is 2 mL (1 mg) once daily.
Adults with Hepatic or Renal Impairment:
In adult patients with liver or renal impairment, a starting dose of one
5 mg tablet every other day is recommended based on pharmacokinetic
data. Dosing recommendation for children with liver or renal impairment
cannot be made due to lack of data
The authors make no claims of the accuracy of the information contained herein; and these suggested doses are not a substitute for clinical
judgment. Neither GlobalRPh Inc. nor any other party involved in the
preparation of this program shall be liable for any special, consequential, or exemplary damages resulting in whole or part from any user's use of or reliance upon this material.PLEASE READ THE DISCLAIMER
BEFORE ACCESSING OR USING THIS SITE. BY ACCESSING OR USING THIS SITE, YOU
AGREE TO BE BOUND BY THE TERMS AND CONDITIONS SET FORTH IN THE DISCLAIMER. Read